MENOK: Multicenter Evaluation of Near Vision and Outdoor Time in Kids Study

Sponsor
The University of New South Wales (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06119243
Collaborator
Queensland University of Technology (Other), New England College of Optometry (Other), State University of New York College of Optometry (Other), University of California, Berkeley (Other)
230
5
24
46
1.9

Study Details

Study Description

Brief Summary

Currently, optical and pharmacological interventions have been developed to prevent the progression of childhood myopia. However, no myopia control strategy has been shown to have complete efficacy in controlling myopia progression in children. One possible reason is that risk factors contributing to the development of myopia were not controlled in previous clinical studies including time outdoors and near vision behaviour. This study aims to quantify time spent outdoors and near vision behavior in myopic children and its impact on myopia control efficacy. The outcomes of this study will guide clinicians on risk management and improve responses to existing treatments for progressive myopia.

Condition or Disease Intervention/Treatment Phase
  • Device: Vivior

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
230 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Multicenter Study of Near Vision Behavior and Outdoor Time in Children Undergoing Myopia Control
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
Nov 1, 2025

Outcome Measures

Primary Outcome Measures

  1. Near viewing duration [12 months]

    Duration during near tasks

  2. Near viewing distance [12 months]

    Distance during near tasks

  3. Outdoor time [12 months]

    Ambient illumination to determine time spent outdoors

Secondary Outcome Measures

  1. Objective cycloplegic central refraction [12 months]

    Change in objective refraction to measure myopia progression

  2. Axial length [12 months]

    Change in axial length to measure myopia progression

  3. Subjective cycloplegic central refraction [12 months]

    Change in subjective refraction to measure myopia progression

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Aged 6 to below 14 years old

  2. Spherical equivalent myopic refractive error greater than -0.50 D

  3. Best corrected logMAR visual acuity of 0.1 or better in each eye

  4. Good ocular and general health that would not preclude them from myopia control

  5. Competent enough in English to fully understand the participant information and consent form

  6. Willing to undergo treatment to slow myopia progression for one year

Exclusion Criteria:
  1. Strabismus at distance or near, amblyopia or significant anisometropia (>1.50 D)

  2. Systemic or ocular conditions that may affect contact lens use (e.g. severe allergy) or refractive development (e.g. ptosis)

  3. Previous history of ocular surgery, trauma or chronic ocular disease that may affect their vision

  4. Ocular or systemic medication use which may interfere or interact with myopia treatment or ocular development

  5. Child, parents or guardians not willing to comply with treatment and/or follow-up schedule and planning to migrate or move during the one-year study duration

Contacts and Locations

Locations

Site City State Country Postal Code
1 School of Optometry, University of California, Berkeley Berkeley California United States 94720
2 New England College of Optometry Boston Massachusetts United States 02115
3 State University of New York (SUNY), College of Optometry New York New York United States 10036
4 School of Optometry and Vision Science, UNSW Sydney New South Wales Australia 2052
5 Optometry and Vision Science, Queensland University of Technology Kelvin Grove Queensland Australia 4059

Sponsors and Collaborators

  • The University of New South Wales
  • Queensland University of Technology
  • New England College of Optometry
  • State University of New York College of Optometry
  • University of California, Berkeley

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Pauline Kang, Senior Lecturer, The University of New South Wales
ClinicalTrials.gov Identifier:
NCT06119243
Other Study ID Numbers:
  • MENOK
First Posted:
Nov 7, 2023
Last Update Posted:
Nov 7, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Keywords provided by Pauline Kang, Senior Lecturer, The University of New South Wales
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 7, 2023